November 10, 2003

FOR: ZOLL Medical Corporation

Chief Financial Officer
ZOLL Medical Corporation
(978) 421-9655
PRESS CONTACT: Robert Minicucci
Corporate Communications Manager
ZOLL Medical Corporation
+1 (978) 421-9832


ZOLL Announces Appointment of New President Of Pinpoint Technologies

Monday, November 10, 2003 – ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of non-invasive cardiac resuscitation devices, today announced that Vane P. Clayton has been appointed President of Pinpoint Technologies, a Division of ZOLL. Pinpoint, founded in 1993, is headquartered in Boulder, CO, and was acquired by ZOLL Medical in October, 1999. Pinpoint develops computer-aided dispatch, billing and other field data collection software for the emergency medical services (EMS) market. These products combined with resuscitation data from ZOLL’s defibrillators to create RescueNet, the world’s only fully integrated Information Management System for resuscitation.

Richard A. Packer, President and Chief Executive Officer of ZOLL commented, “After many years of building a successful company as Pinpoint’s President, David Brown has decided to retire. Mr. Brown has been a valuable member of the ZOLL team, bringing success and leadership since Pinpoint’s inception. We wish him well in his new endeavor.”

Mr. Clayton joins ZOLL from the wireless communications industry, where he most recently was the President of Troy Wireless. In previous positions, he had been the leader of both small and mid-sized organizations. Mr. Clayton received an MBA from Harvard Business School and a BS in Engineering from Purdue University.

Mr. Packer further noted, “To lead Pinpoint in it’s next phase of growth, we are very pleased to welcome Vane to the ZOLL family. We look forward to his immediate contribution. His extensive experience will strengthen our organization.”

ZOLL Medical Corporation (NASDAQ: ZOLL), with worldwide headquarters in Chelmsford, Massachusetts, designs, manufactures, and markets resuscitation solutions. Pacing and defibrillation devices, including LIFECOR, Inc.’s LifeVest™ Wearable Defibrillator and ZOLL’s M Series and AED Plus; and circulatory assist devices such as Advanced Circulatory Systems, Inc.’s ResQPOD™ Circulatory Enhancer and Revivant Corporation’s AutoPulse™; are used by health care professionals, emergency medical service providers, and first responders to diagnose and treat cardiac arrest wherever it may occur. ZOLL also designs and markets software that automates the collection and management of both clinical and non-clinical data. ZOLL has operations in the United States, Canada, the United Kingdom, Germany, France, the Netherlands, and Australia, and business partners in all of the world’s major markets. For more information about ZOLL, its products and partners, visit or call 978-421-9655.

Certain statements contained in this press release, including statements regarding the anticipated development of the Company's business, the intent, belief or current expectations of the Company, its directors or its officers, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 13, 2003.